Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 14, 2025, titled "Zydus receives EIR for the Ambernath API manufacturing facility".
Press Release May 14 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release May 08 2025
- Zydus Receives Final Approval From USFDA for Glatiramer Acetate Injection, the Generic Version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes
- Press Release Apr 30 2025
- Press Release Apr 26 2025
- Press Release Apr 25 2025
Later from Zydus Lifesciences
- Press Release May 20 2025
- Press Release May 23 2025
- Press Release May 28 2025
- Zydus Lifesciences Limited Press Release Jun 02 2025
- Press Release Jun 10 2025
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences